Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lyme Disease | 37 | 2024 | 630 | 7.880 |
Why?
|
Serologic Tests | 16 | 2024 | 383 | 3.490 |
Why?
|
Borrelia burgdorferi | 16 | 2024 | 183 | 3.210 |
Why?
|
Encephalitis Viruses, Tick-Borne | 3 | 2024 | 43 | 2.410 |
Why?
|
Antibodies, Bacterial | 13 | 2024 | 1468 | 2.340 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 9 | 2019 | 507 | 2.220 |
Why?
|
Immunoenzyme Techniques | 10 | 2020 | 1705 | 2.220 |
Why?
|
Borrelia | 5 | 2023 | 66 | 1.790 |
Why?
|
Anaplasmosis | 7 | 2021 | 37 | 1.780 |
Why?
|
Erythema Chronicum Migrans | 4 | 2023 | 48 | 1.760 |
Why?
|
Immunoglobulin M | 14 | 2024 | 1529 | 1.690 |
Why?
|
Encephalitis, Tick-Borne | 2 | 2024 | 37 | 1.550 |
Why?
|
Anaplasma phagocytophilum | 3 | 2020 | 37 | 1.530 |
Why?
|
Ehrlichiosis | 5 | 2021 | 28 | 1.250 |
Why?
|
Strongyloides stercoralis | 2 | 2020 | 23 | 1.180 |
Why?
|
Strongyloidiasis | 2 | 2020 | 27 | 1.170 |
Why?
|
Reagent Kits, Diagnostic | 2 | 2024 | 238 | 1.150 |
Why?
|
Lyme Neuroborreliosis | 4 | 2022 | 50 | 1.030 |
Why?
|
Babesiosis | 6 | 2021 | 92 | 1.020 |
Why?
|
Bacteriological Techniques | 4 | 2017 | 279 | 0.990 |
Why?
|
Borrelia Infections | 2 | 2015 | 17 | 0.960 |
Why?
|
Sensitivity and Specificity | 26 | 2024 | 14641 | 0.880 |
Why?
|
Central Nervous System Infections | 1 | 2024 | 61 | 0.870 |
Why?
|
Clinical Laboratory Techniques | 6 | 2024 | 748 | 0.860 |
Why?
|
Immunoglobulin G | 11 | 2024 | 4540 | 0.850 |
Why?
|
Diagnosis, Differential | 24 | 2020 | 12951 | 0.820 |
Why?
|
Relapsing Fever | 2 | 2020 | 24 | 0.780 |
Why?
|
Travel | 4 | 2018 | 785 | 0.740 |
Why?
|
Fungi | 2 | 2024 | 339 | 0.730 |
Why?
|
AIDS-Related Opportunistic Infections | 2 | 2014 | 662 | 0.730 |
Why?
|
Antibodies, Viral | 7 | 2024 | 3142 | 0.720 |
Why?
|
Lung | 8 | 2024 | 9985 | 0.720 |
Why?
|
Cytodiagnosis | 2 | 2022 | 442 | 0.690 |
Why?
|
HTLV-I Infections | 1 | 2020 | 103 | 0.670 |
Why?
|
Bacterial Typing Techniques | 4 | 2018 | 260 | 0.670 |
Why?
|
Streptococcal Infections | 2 | 2014 | 617 | 0.660 |
Why?
|
Complement C6 | 1 | 2018 | 21 | 0.650 |
Why?
|
Fever | 11 | 2019 | 1617 | 0.650 |
Why?
|
Diagnostic Errors | 6 | 2014 | 1263 | 0.640 |
Why?
|
Antigens, Bacterial | 4 | 2023 | 1155 | 0.630 |
Why?
|
Meningoencephalitis | 1 | 2019 | 83 | 0.610 |
Why?
|
Glossitis, Benign Migratory | 1 | 2017 | 7 | 0.610 |
Why?
|
Tularemia | 3 | 2020 | 42 | 0.600 |
Why?
|
Paresthesia | 1 | 2018 | 162 | 0.590 |
Why?
|
Pathology, Clinical | 2 | 2014 | 375 | 0.570 |
Why?
|
Parasite Egg Count | 2 | 2006 | 29 | 0.550 |
Why?
|
Duodenum | 1 | 2020 | 485 | 0.550 |
Why?
|
Lipoproteins | 2 | 2011 | 881 | 0.510 |
Why?
|
Candida | 2 | 2007 | 173 | 0.510 |
Why?
|
Algorithms | 10 | 2024 | 13959 | 0.510 |
Why?
|
Mycobacterium | 2 | 2018 | 250 | 0.500 |
Why?
|
Gram-Negative Bacteria | 2 | 2013 | 272 | 0.490 |
Why?
|
Fusobacterium necrophorum | 1 | 2014 | 14 | 0.490 |
Why?
|
Streptococcus bovis | 1 | 2014 | 4 | 0.490 |
Why?
|
Cavernous Sinus Thrombosis | 1 | 2014 | 14 | 0.490 |
Why?
|
Treponema pallidum | 1 | 2014 | 47 | 0.490 |
Why?
|
Lemierre Syndrome | 1 | 2014 | 14 | 0.480 |
Why?
|
Tick-Borne Diseases | 4 | 2020 | 36 | 0.470 |
Why?
|
Superinfection | 1 | 2014 | 64 | 0.470 |
Why?
|
Lymphadenitis | 1 | 2014 | 98 | 0.450 |
Why?
|
Syphilis | 2 | 2014 | 243 | 0.450 |
Why?
|
Streptococcus mitis | 1 | 2013 | 7 | 0.450 |
Why?
|
Parotid Gland | 1 | 2014 | 175 | 0.450 |
Why?
|
Bacteria, Aerobic | 1 | 2013 | 24 | 0.440 |
Why?
|
Humans | 114 | 2024 | 758381 | 0.440 |
Why?
|
False Negative Reactions | 3 | 2020 | 573 | 0.440 |
Why?
|
Coccidioidomycosis | 2 | 2010 | 37 | 0.430 |
Why?
|
Diplopia | 1 | 2014 | 215 | 0.430 |
Why?
|
Tuberculosis | 3 | 2012 | 2001 | 0.420 |
Why?
|
Microbiological Techniques | 1 | 2013 | 98 | 0.420 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2014 | 242 | 0.420 |
Why?
|
Communicable Diseases | 4 | 2021 | 877 | 0.410 |
Why?
|
Sarcocystidae | 1 | 2011 | 2 | 0.410 |
Why?
|
Meningitis, Bacterial | 1 | 2014 | 221 | 0.410 |
Why?
|
Gram-Positive Bacteria | 1 | 2013 | 178 | 0.400 |
Why?
|
Coccidiosis | 1 | 2011 | 10 | 0.400 |
Why?
|
Francisella tularensis | 2 | 2010 | 62 | 0.400 |
Why?
|
Feces | 3 | 2011 | 1457 | 0.400 |
Why?
|
Nucleic Acid Amplification Techniques | 2 | 2017 | 328 | 0.400 |
Why?
|
Tuberculosis, Gastrointestinal | 1 | 2011 | 21 | 0.390 |
Why?
|
Rheumatology | 4 | 2021 | 611 | 0.390 |
Why?
|
Sulfadiazine | 1 | 2010 | 18 | 0.370 |
Why?
|
Aspergillus niger | 1 | 2010 | 18 | 0.370 |
Why?
|
Confusion | 4 | 2020 | 279 | 0.360 |
Why?
|
Mycoses | 3 | 2024 | 386 | 0.360 |
Why?
|
Peritoneum | 1 | 2011 | 224 | 0.350 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2015 | 420 | 0.350 |
Why?
|
Thrombocytopenia | 1 | 2018 | 1172 | 0.350 |
Why?
|
Neutropenia | 1 | 2015 | 884 | 0.350 |
Why?
|
Bacterial Proteins | 3 | 2018 | 3824 | 0.340 |
Why?
|
Bites and Stings | 1 | 2010 | 93 | 0.340 |
Why?
|
Meningitis | 3 | 2022 | 218 | 0.340 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2017 | 611 | 0.330 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 6 | 2023 | 3801 | 0.330 |
Why?
|
Cats | 1 | 2010 | 975 | 0.330 |
Why?
|
Peritonitis | 1 | 2011 | 369 | 0.330 |
Why?
|
Cord Factors | 1 | 2008 | 6 | 0.320 |
Why?
|
Encephalitis Virus, Eastern Equine | 1 | 2008 | 12 | 0.320 |
Why?
|
Encephalomyelitis, Eastern Equine | 1 | 2008 | 14 | 0.320 |
Why?
|
Aspergillosis | 1 | 2010 | 243 | 0.320 |
Why?
|
Vitreous Body | 1 | 2010 | 399 | 0.310 |
Why?
|
Mycobacterium marinum | 1 | 2008 | 29 | 0.310 |
Why?
|
Headache | 4 | 2019 | 1248 | 0.300 |
Why?
|
Endophthalmitis | 1 | 2010 | 257 | 0.300 |
Why?
|
Meningitis, Cryptococcal | 1 | 2008 | 66 | 0.290 |
Why?
|
Streptococcus pneumoniae | 1 | 2013 | 732 | 0.290 |
Why?
|
Leukocyte Count | 2 | 2014 | 1593 | 0.290 |
Why?
|
Immunoassay | 2 | 2024 | 746 | 0.290 |
Why?
|
Cryptococcosis | 1 | 2008 | 104 | 0.290 |
Why?
|
Parasites | 2 | 2006 | 161 | 0.280 |
Why?
|
Plasmodium falciparum | 2 | 2021 | 1742 | 0.280 |
Why?
|
Laboratories, Hospital | 2 | 2021 | 192 | 0.270 |
Why?
|
Fungemia | 1 | 2007 | 58 | 0.270 |
Why?
|
Dyspnea | 1 | 2014 | 1344 | 0.270 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2009 | 447 | 0.260 |
Why?
|
Hematologic Tests | 1 | 2007 | 238 | 0.260 |
Why?
|
Malaria | 1 | 2015 | 1226 | 0.260 |
Why?
|
Immunoblotting | 3 | 2019 | 1647 | 0.250 |
Why?
|
HIV Infections | 4 | 2023 | 17275 | 0.250 |
Why?
|
Influenza, Human | 2 | 2022 | 1516 | 0.250 |
Why?
|
Mycobacterium tuberculosis | 4 | 2018 | 1903 | 0.250 |
Why?
|
Diagnostic Tests, Routine | 3 | 2019 | 787 | 0.240 |
Why?
|
Neurology | 3 | 2021 | 778 | 0.230 |
Why?
|
Candidiasis | 1 | 2007 | 363 | 0.230 |
Why?
|
Mycology | 2 | 2013 | 13 | 0.230 |
Why?
|
Diarrhea | 3 | 2020 | 1317 | 0.230 |
Why?
|
Anti-Infective Agents | 2 | 2010 | 981 | 0.220 |
Why?
|
Platelet Count | 1 | 2006 | 775 | 0.220 |
Why?
|
Phylogeny | 3 | 2020 | 2774 | 0.220 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2015 | 2125 | 0.220 |
Why?
|
Ixodes | 2 | 2020 | 40 | 0.220 |
Why?
|
Tomography, X-Ray Computed | 8 | 2024 | 20500 | 0.220 |
Why?
|
Lymph Nodes | 1 | 2014 | 3485 | 0.210 |
Why?
|
Exanthema | 4 | 2016 | 504 | 0.210 |
Why?
|
New England | 2 | 2024 | 1053 | 0.210 |
Why?
|
Hematology | 1 | 2006 | 241 | 0.210 |
Why?
|
Yeasts | 2 | 2013 | 279 | 0.200 |
Why?
|
Plague | 1 | 2002 | 20 | 0.200 |
Why?
|
Smallpox | 1 | 2002 | 43 | 0.200 |
Why?
|
Fatal Outcome | 4 | 2015 | 1829 | 0.200 |
Why?
|
Muscle Weakness | 1 | 2005 | 413 | 0.200 |
Why?
|
Anthrax | 1 | 2002 | 87 | 0.200 |
Why?
|
Intestines | 3 | 2020 | 1906 | 0.190 |
Why?
|
Pneumonia | 4 | 2022 | 2129 | 0.190 |
Why?
|
Bioterrorism | 1 | 2002 | 144 | 0.190 |
Why?
|
Immunocompromised Host | 3 | 2014 | 856 | 0.190 |
Why?
|
Herpesviridae Infections | 1 | 2022 | 270 | 0.190 |
Why?
|
DNA, Bacterial | 3 | 2021 | 1456 | 0.180 |
Why?
|
Fatigue | 2 | 2020 | 1542 | 0.180 |
Why?
|
Polymerase Chain Reaction | 3 | 2019 | 6068 | 0.180 |
Why?
|
Male | 31 | 2024 | 358742 | 0.180 |
Why?
|
Metagenomics | 1 | 2024 | 457 | 0.170 |
Why?
|
Malaria, Falciparum | 2 | 2021 | 1076 | 0.170 |
Why?
|
Clinical Enzyme Tests | 1 | 2019 | 115 | 0.170 |
Why?
|
Abdominal Pain | 2 | 2020 | 1063 | 0.170 |
Why?
|
Radiography | 4 | 2015 | 6955 | 0.170 |
Why?
|
Speech Disorders | 1 | 2020 | 180 | 0.170 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 2020 | 142 | 0.170 |
Why?
|
Disease Notification | 1 | 2020 | 96 | 0.170 |
Why?
|
Gonorrhea | 1 | 2023 | 346 | 0.160 |
Why?
|
Middle Aged | 22 | 2024 | 219560 | 0.160 |
Why?
|
Adult | 20 | 2024 | 219916 | 0.160 |
Why?
|
Blood Cell Count | 1 | 2020 | 395 | 0.160 |
Why?
|
Animals | 19 | 2024 | 167777 | 0.160 |
Why?
|
Canada | 1 | 2024 | 2111 | 0.160 |
Why?
|
Encephalitis | 1 | 2022 | 438 | 0.160 |
Why?
|
Tuberculosis, Cutaneous | 1 | 2018 | 17 | 0.160 |
Why?
|
Blotting, Western | 5 | 2019 | 5031 | 0.160 |
Why?
|
Europe | 2 | 2018 | 3420 | 0.160 |
Why?
|
Fishes | 1 | 2022 | 601 | 0.160 |
Why?
|
History, 21st Century | 1 | 2024 | 1573 | 0.150 |
Why?
|
Lung Neoplasms | 2 | 2022 | 13245 | 0.150 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2020 | 219 | 0.150 |
Why?
|
Mycobacterium Infections | 1 | 2018 | 121 | 0.150 |
Why?
|
Cerebrospinal Fluid | 1 | 2020 | 544 | 0.150 |
Why?
|
Transaminases | 1 | 2018 | 196 | 0.150 |
Why?
|
Brain | 4 | 2021 | 26951 | 0.150 |
Why?
|
Endoscopy, Digestive System | 1 | 2020 | 351 | 0.140 |
Why?
|
Abdominal Wall | 1 | 2018 | 165 | 0.140 |
Why?
|
Magnetic Resonance Imaging | 7 | 2021 | 36285 | 0.140 |
Why?
|
Herpesvirus 1, Human | 1 | 2022 | 753 | 0.140 |
Why?
|
ROC Curve | 2 | 2018 | 3563 | 0.140 |
Why?
|
Antibodies, Neutralizing | 3 | 2022 | 1931 | 0.140 |
Why?
|
Spermatozoa | 1 | 2021 | 631 | 0.140 |
Why?
|
Genome, Viral | 1 | 2020 | 658 | 0.140 |
Why?
|
Bacterial Infections | 3 | 2013 | 1401 | 0.140 |
Why?
|
Antifungal Agents | 1 | 2022 | 749 | 0.140 |
Why?
|
RNA, Ribosomal, 16S | 3 | 2018 | 1006 | 0.140 |
Why?
|
Female | 26 | 2024 | 390316 | 0.140 |
Why?
|
Microvessels | 1 | 2021 | 572 | 0.140 |
Why?
|
History, 20th Century | 1 | 2024 | 2772 | 0.130 |
Why?
|
Liver Transplantation | 1 | 2008 | 2325 | 0.130 |
Why?
|
Erythema | 1 | 2017 | 262 | 0.130 |
Why?
|
Babesia microti | 1 | 2016 | 31 | 0.130 |
Why?
|
Blastomyces | 1 | 2015 | 10 | 0.130 |
Why?
|
Eosinophilia | 2 | 2014 | 559 | 0.130 |
Why?
|
Blastomycosis | 1 | 2015 | 14 | 0.130 |
Why?
|
Chills | 1 | 2015 | 17 | 0.130 |
Why?
|
High-Throughput Screening Assays | 2 | 2019 | 933 | 0.130 |
Why?
|
Containment of Biohazards | 1 | 2015 | 37 | 0.130 |
Why?
|
Cerebral Infarction | 1 | 2020 | 981 | 0.130 |
Why?
|
Stomach | 1 | 2020 | 694 | 0.130 |
Why?
|
Liberia | 1 | 2015 | 174 | 0.120 |
Why?
|
Bartonella Infections | 1 | 2014 | 21 | 0.120 |
Why?
|
Parotitis | 1 | 2014 | 28 | 0.120 |
Why?
|
Anti-Bacterial Agents | 7 | 2023 | 7403 | 0.120 |
Why?
|
Weight Loss | 2 | 2020 | 2671 | 0.120 |
Why?
|
Back Pain | 1 | 2018 | 543 | 0.120 |
Why?
|
Foot | 1 | 2018 | 573 | 0.120 |
Why?
|
United States | 11 | 2024 | 72140 | 0.120 |
Why?
|
Kidney Transplantation | 1 | 2009 | 4217 | 0.120 |
Why?
|
Tenosynovitis | 1 | 2014 | 57 | 0.120 |
Why?
|
Kidney | 1 | 2009 | 7016 | 0.120 |
Why?
|
Blood Donors | 1 | 2016 | 343 | 0.110 |
Why?
|
Thoracic Vertebrae | 1 | 2018 | 596 | 0.110 |
Why?
|
Photophobia | 1 | 2014 | 71 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2022 | 1160 | 0.110 |
Why?
|
Life Cycle Stages | 1 | 2014 | 160 | 0.110 |
Why?
|
Lung Diseases | 2 | 2022 | 1910 | 0.110 |
Why?
|
Peptide Initiation Factors | 3 | 1998 | 55 | 0.110 |
Why?
|
Bacteria, Anaerobic | 1 | 2013 | 70 | 0.110 |
Why?
|
Physician Executives | 1 | 2014 | 133 | 0.110 |
Why?
|
Work | 1 | 2014 | 194 | 0.110 |
Why?
|
Endemic Diseases | 3 | 2020 | 190 | 0.110 |
Why?
|
Myocarditis | 1 | 2020 | 766 | 0.110 |
Why?
|
Tuberculin Test | 2 | 2011 | 206 | 0.110 |
Why?
|
RNA, Viral | 1 | 2021 | 2836 | 0.110 |
Why?
|
Lymphatic Diseases | 1 | 2014 | 319 | 0.110 |
Why?
|
Retrospective Studies | 8 | 2024 | 80170 | 0.110 |
Why?
|
Pharyngitis | 1 | 2014 | 219 | 0.110 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2018 | 708 | 0.100 |
Why?
|
Orbital Diseases | 1 | 2014 | 178 | 0.100 |
Why?
|
Protozoan Infections | 1 | 2011 | 39 | 0.100 |
Why?
|
Early Diagnosis | 1 | 2017 | 1177 | 0.100 |
Why?
|
Enterobacteriaceae | 1 | 2013 | 172 | 0.100 |
Why?
|
RNA, Bacterial | 1 | 2013 | 385 | 0.100 |
Why?
|
Ileus | 1 | 2011 | 57 | 0.100 |
Why?
|
Societies, Medical | 2 | 2020 | 3891 | 0.100 |
Why?
|
Herpes Zoster | 1 | 2014 | 251 | 0.100 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2013 | 237 | 0.100 |
Why?
|
Nausea | 1 | 2014 | 677 | 0.100 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2024 | 3615 | 0.090 |
Why?
|
Prospective Studies | 5 | 2023 | 54136 | 0.090 |
Why?
|
Coccidioides | 1 | 2010 | 18 | 0.090 |
Why?
|
Antibodies, Fungal | 1 | 2010 | 34 | 0.090 |
Why?
|
Abscess | 1 | 2014 | 605 | 0.090 |
Why?
|
Population Surveillance | 1 | 2021 | 2606 | 0.090 |
Why?
|
Hypokalemia | 1 | 2011 | 152 | 0.090 |
Why?
|
Specimen Handling | 2 | 2024 | 707 | 0.090 |
Why?
|
Uveitis, Posterior | 1 | 2010 | 45 | 0.090 |
Why?
|
Virus Diseases | 2 | 2008 | 719 | 0.090 |
Why?
|
Community-Acquired Infections | 2 | 2015 | 460 | 0.090 |
Why?
|
Societies | 2 | 2021 | 108 | 0.090 |
Why?
|
Paralysis | 1 | 2011 | 251 | 0.090 |
Why?
|
Carotid Arteries | 1 | 2014 | 939 | 0.090 |
Why?
|
Reference Standards | 1 | 2013 | 1003 | 0.090 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2009 | 66 | 0.090 |
Why?
|
Hospitals, General | 1 | 2014 | 795 | 0.090 |
Why?
|
Necrosis | 2 | 2015 | 1604 | 0.090 |
Why?
|
Prednisone | 1 | 2014 | 1565 | 0.080 |
Why?
|
Brain Diseases | 1 | 2019 | 1541 | 0.080 |
Why?
|
Automation | 1 | 2012 | 581 | 0.080 |
Why?
|
Serotyping | 1 | 2010 | 324 | 0.080 |
Why?
|
Fluorescent Antibody Technique | 1 | 2013 | 2470 | 0.080 |
Why?
|
Dehydration | 1 | 2010 | 216 | 0.080 |
Why?
|
Fundus Oculi | 1 | 2010 | 541 | 0.080 |
Why?
|
Predictive Value of Tests | 5 | 2021 | 15225 | 0.080 |
Why?
|
Lung Diseases, Fungal | 1 | 2009 | 126 | 0.080 |
Why?
|
Brain Injuries | 1 | 2021 | 2044 | 0.080 |
Why?
|
Pulmonary Emphysema | 1 | 2014 | 688 | 0.080 |
Why?
|
Cellulitis | 1 | 2010 | 207 | 0.080 |
Why?
|
Blood Gas Analysis | 1 | 2009 | 377 | 0.080 |
Why?
|
Cross Reactions | 2 | 2020 | 818 | 0.080 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3671 | 0.080 |
Why?
|
Disease Vectors | 1 | 2008 | 61 | 0.080 |
Why?
|
Urinalysis | 1 | 2010 | 368 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2021 | 3339 | 0.080 |
Why?
|
Adolescent | 11 | 2020 | 87888 | 0.080 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6520 | 0.080 |
Why?
|
Neutrophils | 1 | 2021 | 3765 | 0.080 |
Why?
|
Chronic Disease | 2 | 2014 | 9266 | 0.080 |
Why?
|
Academic Medical Centers | 2 | 2018 | 2751 | 0.080 |
Why?
|
Biopsy | 1 | 2020 | 6768 | 0.070 |
Why?
|
Acute Kidney Injury | 2 | 2010 | 1926 | 0.070 |
Why?
|
Cryptococcus neoformans | 1 | 2008 | 121 | 0.070 |
Why?
|
North America | 2 | 2021 | 1276 | 0.070 |
Why?
|
Immunoglobulin A | 2 | 2020 | 979 | 0.070 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2017 | 3758 | 0.070 |
Why?
|
Young Adult | 9 | 2020 | 58808 | 0.070 |
Why?
|
Opportunistic Infections | 1 | 2009 | 375 | 0.070 |
Why?
|
Candida glabrata | 1 | 2007 | 37 | 0.070 |
Why?
|
Dientamoeba | 1 | 2006 | 2 | 0.070 |
Why?
|
Giardia lamblia | 1 | 2006 | 23 | 0.070 |
Why?
|
Colony Count, Microbial | 1 | 2007 | 328 | 0.070 |
Why?
|
Diabetic Ketoacidosis | 1 | 2009 | 253 | 0.070 |
Why?
|
Migraine Disorders | 1 | 2019 | 1694 | 0.070 |
Why?
|
Spinal Puncture | 1 | 2008 | 281 | 0.070 |
Why?
|
Microfluidics | 2 | 2022 | 652 | 0.070 |
Why?
|
Cryptosporidium parvum | 1 | 2006 | 35 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15785 | 0.070 |
Why?
|
Onchocerciasis | 1 | 2005 | 28 | 0.060 |
Why?
|
Child | 11 | 2023 | 79813 | 0.060 |
Why?
|
Respiratory Insufficiency | 2 | 2015 | 1230 | 0.060 |
Why?
|
Infant | 5 | 2020 | 36054 | 0.060 |
Why?
|
Pain | 2 | 2014 | 5065 | 0.060 |
Why?
|
Lung Diseases, Interstitial | 1 | 2014 | 909 | 0.060 |
Why?
|
Comorbidity | 2 | 2020 | 10495 | 0.060 |
Why?
|
Basal Ganglia | 1 | 2008 | 552 | 0.060 |
Why?
|
Peritoneal Neoplasms | 1 | 2011 | 707 | 0.060 |
Why?
|
Glucocorticoids | 1 | 2014 | 2144 | 0.060 |
Why?
|
Mass Screening | 2 | 2022 | 5425 | 0.060 |
Why?
|
Genes, Bacterial | 1 | 2008 | 1071 | 0.060 |
Why?
|
Biopsy, Needle | 1 | 2009 | 1630 | 0.060 |
Why?
|
Aged | 9 | 2020 | 168217 | 0.060 |
Why?
|
Sequence Alignment | 1 | 2008 | 2176 | 0.060 |
Why?
|
Renal Insufficiency | 1 | 2009 | 809 | 0.060 |
Why?
|
Candida albicans | 1 | 2007 | 374 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7377 | 0.050 |
Why?
|
Vision Disorders | 1 | 2010 | 1084 | 0.050 |
Why?
|
Genomics | 1 | 2019 | 5789 | 0.050 |
Why?
|
Single-Blind Method | 1 | 2007 | 1570 | 0.050 |
Why?
|
Massachusetts | 2 | 2020 | 8823 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3076 | 0.050 |
Why?
|
Variola virus | 1 | 2002 | 11 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3196 | 0.050 |
Why?
|
Liver Cirrhosis | 2 | 2015 | 1930 | 0.050 |
Why?
|
Hepatitis B | 1 | 2008 | 701 | 0.050 |
Why?
|
Molecular Sequence Data | 4 | 2014 | 17617 | 0.050 |
Why?
|
Yersinia pestis | 1 | 2002 | 33 | 0.050 |
Why?
|
Herpesvirus 3, Human | 1 | 2022 | 158 | 0.050 |
Why?
|
Bacillus anthracis | 1 | 2002 | 122 | 0.050 |
Why?
|
Inflammation | 1 | 2021 | 10719 | 0.050 |
Why?
|
Ciprofloxacin | 1 | 2023 | 312 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7810 | 0.050 |
Why?
|
RNA Caps | 2 | 1998 | 73 | 0.050 |
Why?
|
Herpesvirus 2, Human | 1 | 2022 | 191 | 0.050 |
Why?
|
Insect Repellents | 1 | 2020 | 17 | 0.050 |
Why?
|
Coloring Agents | 1 | 2023 | 560 | 0.050 |
Why?
|
Polyneuropathies | 1 | 2022 | 137 | 0.050 |
Why?
|
Complement C5 | 1 | 2021 | 106 | 0.050 |
Why?
|
Neisseria gonorrhoeae | 1 | 2023 | 239 | 0.050 |
Why?
|
Prostatic Hyperplasia | 1 | 2005 | 530 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20052 | 0.040 |
Why?
|
Cost-Benefit Analysis | 1 | 2013 | 5484 | 0.040 |
Why?
|
Infectious Disease Medicine | 1 | 2020 | 49 | 0.040 |
Why?
|
Colorado Tick Fever | 1 | 2020 | 4 | 0.040 |
Why?
|
Time-Lapse Imaging | 1 | 2021 | 192 | 0.040 |
Why?
|
Rocky Mountain Spotted Fever | 1 | 2020 | 19 | 0.040 |
Why?
|
Mammary Glands, Animal | 1 | 2001 | 271 | 0.040 |
Why?
|
Histocytochemistry | 1 | 2021 | 700 | 0.040 |
Why?
|
Leg | 1 | 2005 | 1087 | 0.040 |
Why?
|
Carcinoma | 1 | 2011 | 2330 | 0.040 |
Why?
|
Child, Preschool | 5 | 2020 | 42058 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2022 | 651 | 0.040 |
Why?
|
Cyclin D1 | 1 | 2001 | 451 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2021 | 22031 | 0.040 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2006 | 831 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 617 | 0.040 |
Why?
|
Blood Sedimentation | 1 | 2019 | 234 | 0.040 |
Why?
|
Mycolic Acids | 1 | 2018 | 54 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2001 | 698 | 0.040 |
Why?
|
Coronavirus | 1 | 2020 | 149 | 0.040 |
Why?
|
Base Composition | 1 | 2018 | 289 | 0.040 |
Why?
|
Plasmids | 1 | 2023 | 2275 | 0.040 |
Why?
|
Research Report | 1 | 2021 | 367 | 0.040 |
Why?
|
Hepatitis C | 1 | 2008 | 1579 | 0.040 |
Why?
|
Chemokines | 1 | 2021 | 961 | 0.040 |
Why?
|
Cefuroxime | 1 | 2016 | 23 | 0.040 |
Why?
|
Alcoholism | 1 | 2008 | 1964 | 0.040 |
Why?
|
Microbial Sensitivity Tests | 1 | 2023 | 1945 | 0.040 |
Why?
|
Skin | 1 | 2010 | 4464 | 0.030 |
Why?
|
Borrelia burgdorferi Group | 1 | 2016 | 97 | 0.030 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2020 | 864 | 0.030 |
Why?
|
Amino Acid Sequence | 1 | 2008 | 13447 | 0.030 |
Why?
|
Italy | 1 | 2018 | 839 | 0.030 |
Why?
|
Cytokines | 2 | 2021 | 7338 | 0.030 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 1997 | 377 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 1998 | 5779 | 0.030 |
Why?
|
Incidence | 3 | 2021 | 21273 | 0.030 |
Why?
|
Microscopy | 1 | 2021 | 884 | 0.030 |
Why?
|
Drug Resistance, Bacterial | 1 | 2023 | 1055 | 0.030 |
Why?
|
Arthritis, Infectious | 1 | 2019 | 345 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2006 | 5864 | 0.030 |
Why?
|
Zoonoses | 1 | 2016 | 178 | 0.030 |
Why?
|
Amoxicillin | 1 | 2016 | 180 | 0.030 |
Why?
|
Sequence Analysis, DNA | 2 | 2018 | 4711 | 0.030 |
Why?
|
Laboratories | 1 | 2019 | 460 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2020 | 58681 | 0.030 |
Why?
|
Central Nervous System | 1 | 2022 | 1333 | 0.030 |
Why?
|
Risk Factors | 3 | 2020 | 73806 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 2021 | 1674 | 0.030 |
Why?
|
beta-Lactams | 1 | 2016 | 157 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2021 | 1018 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 782 | 0.030 |
Why?
|
Doxycycline | 1 | 2016 | 341 | 0.030 |
Why?
|
Pregnancy | 2 | 2015 | 29742 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 1998 | 989 | 0.030 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1996 | 783 | 0.030 |
Why?
|
Kidney Tubules | 1 | 2015 | 449 | 0.030 |
Why?
|
DNA, Ribosomal | 1 | 2014 | 285 | 0.030 |
Why?
|
Genes | 1 | 1997 | 1845 | 0.030 |
Why?
|
Nucleic Acid Hybridization | 1 | 2014 | 1304 | 0.030 |
Why?
|
Proteome | 1 | 2022 | 1855 | 0.030 |
Why?
|
Eukaryotic Initiation Factor-4E | 3 | 1998 | 112 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2023 | 26182 | 0.020 |
Why?
|
Delayed Diagnosis | 1 | 2015 | 463 | 0.020 |
Why?
|
Enterobacteriaceae Infections | 1 | 2013 | 192 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2020 | 1755 | 0.020 |
Why?
|
Consensus | 1 | 2020 | 3099 | 0.020 |
Why?
|
Quality Control | 1 | 2013 | 825 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 1998 | 9575 | 0.020 |
Why?
|
Bronchoscopy | 1 | 2015 | 910 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3816 | 0.020 |
Why?
|
Acute Disease | 1 | 2019 | 7225 | 0.020 |
Why?
|
Genotype | 1 | 2023 | 12945 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 1997 | 4624 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10112 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2019 | 3812 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9304 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2697 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2021 | 3732 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3888 | 0.020 |
Why?
|
Cough | 1 | 2010 | 594 | 0.020 |
Why?
|
Filaricides | 1 | 2005 | 10 | 0.020 |
Why?
|
Ofloxacin | 1 | 2006 | 66 | 0.020 |
Why?
|
Penicillin G Benzathine | 1 | 2005 | 25 | 0.020 |
Why?
|
Syphilis Serodiagnosis | 1 | 2005 | 37 | 0.020 |
Why?
|
Ivermectin | 1 | 2005 | 46 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2008 | 15638 | 0.020 |
Why?
|
Hemoptysis | 1 | 2006 | 152 | 0.020 |
Why?
|
Metronidazole | 1 | 2006 | 231 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2016 | 25953 | 0.010 |
Why?
|
Prevalence | 1 | 2021 | 15646 | 0.010 |
Why?
|
Aortography | 1 | 2005 | 420 | 0.010 |
Why?
|
Tumor Cells, Cultured | 2 | 2001 | 6127 | 0.010 |
Why?
|
Mammary Tumor Virus, Mouse | 1 | 2001 | 41 | 0.010 |
Why?
|
HeLa Cells | 2 | 1998 | 3096 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8611 | 0.010 |
Why?
|
3T3 Cells | 1 | 2001 | 1084 | 0.010 |
Why?
|
Lactation | 1 | 2001 | 397 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 23883 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1996 | 11894 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1998 | 777 | 0.010 |
Why?
|
HL-60 Cells | 1 | 1998 | 363 | 0.010 |
Why?
|
Aorta | 1 | 2005 | 2037 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41252 | 0.010 |
Why?
|
Hybrid Cells | 1 | 1997 | 422 | 0.010 |
Why?
|
Upstream Stimulatory Factors | 1 | 1996 | 18 | 0.010 |
Why?
|
Base Sequence | 2 | 1998 | 12436 | 0.010 |
Why?
|
Cross-Linking Reagents | 1 | 1998 | 685 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1998 | 1991 | 0.010 |
Why?
|
Cell Division | 1 | 2001 | 4459 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 64379 | 0.010 |
Why?
|
Transcription, Genetic | 2 | 1998 | 7590 | 0.010 |
Why?
|
Ultraviolet Rays | 1 | 1998 | 1076 | 0.010 |
Why?
|
Cricetinae | 1 | 1997 | 2426 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1996 | 1693 | 0.010 |
Why?
|
Cell Differentiation | 2 | 2001 | 11471 | 0.010 |
Why?
|
Ultrasonography | 1 | 2005 | 5952 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2001 | 3380 | 0.010 |
Why?
|
Down-Regulation | 1 | 1998 | 2905 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2001 | 3602 | 0.010 |
Why?
|
Binding Sites | 1 | 1998 | 6036 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2001 | 9518 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1996 | 2105 | 0.010 |
Why?
|
Transfection | 1 | 1996 | 5779 | 0.000 |
Why?
|
Recombinant Fusion Proteins | 1 | 1996 | 3734 | 0.000 |
Why?
|
Models, Genetic | 1 | 1996 | 3441 | 0.000 |
Why?
|
Pyrimidines | 1 | 1998 | 3006 | 0.000 |
Why?
|
Fibroblasts | 1 | 1996 | 4087 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1998 | 12760 | 0.000 |
Why?
|
Mice | 2 | 2001 | 81107 | 0.000 |
Why?
|
Cell Line | 1 | 1996 | 15594 | 0.000 |
Why?
|
Rats | 1 | 1996 | 23681 | 0.000 |
Why?
|
Transcription Factors | 1 | 1996 | 12096 | 0.000 |
Why?
|